McKesson’s share price fell amid concerns over drug pricing
McKesson Corporation closed at $796.35 per share on July 15, 2026, with a market capitalization of $93.23 billion.
The company’s share price fell due to concerns over lower drug pricing, which could pressure distributor margins.
McKesson posted a one-month return of 9.60% and a 52-week return of 15.82%.
The company’s investment thesis remains unchanged, with defensive growth characteristics and scale advantages.